Page 2 - Anges Inc News Today

Vasomune Therapeutics and AnGes drug candidate AV-001 Receives Positive Recommendation from the IDSMB for AV001-004 Phase 2a Study

DUBLIN--(BUSINESS WIRE)--The "COVID-19 - Competitive Landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "COVID-19 Competitive landscape 2023" report provides comprehensive insights about 400+ companies and 500+ drugs in COVID-19 Competitive landscape. It covers the therapeutics assessme...

/PRNewswire/ -- DelveInsights Atherosclerotic Cardiovascular Disease Market Insights report includes a comprehensive understanding of current treatment...

/PRNewswire/ -- DelveInsights Peripheral Artery Disease Market Insights report provides the current and forecast market analysis, individual leading...

Resources prioritized to advance avexitide in hyperinsulinemic hypoglycemia indicationsActive discussions underway with potential partners to advance late-stage virology programsReduction in... -Today at 04:06 pm- MarketScreener

/PRNewswire/ -- DelveInsights Atherosclerosis Market Insights report includes a comprehensive understanding of current treatment practices, atherosclerosis...

Dublin, June 22, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...

/PRNewswire/ -- The "Global Gene Therapy Market Size, Trends, and Growth Opportunity, By Vector Type, Method, Application, End User By Region and forecast till...

May 31, 2023 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO ... | May 31, 2023

Brickell Biotech (NASDAQ:BBI – Get Rating) and bluebird bio (NASDAQ:BLUE – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Analyst Recommendations This is a breakdown of recent recommendations […]